News

The Food and Drug Administration (FDA) has granted approval for a groundbreaking treatment for sickle cell disease, a debilitating condition affecting over 100,000 Americans, primarily from the Black community. Developed …

AstraZeneca, the pharmaceutical company renowned for developing one of the COVID-19 vaccines, has entered into a partnership with Absci, a U.S.-based artificial intelligence (AI) biologics firm. The collaboration involves an …

AB Science SA has announced that its masitinib in sickle cell disease is among the 19 projects to be funded under the “Hospital-University Research in Health” program. This program, part …

The global Artificial Intelligence (AI) in Animal Health market, as highlighted in the report released on November 20, 2023, has experienced significant growth, reaching a valuation of USD 901.81 million …

Sickle cell disease, affecting over 100,000 Americans, particularly impacts one in 365 African American babies born today. Danielle Lee, diagnosed before birth, endured unimaginable pain due to the genetic blood …

Jasmine Smith, the CEO of Rejuve.AI, a Web3-based wellness app, emphasized in an interview with Cointelegraph that decentralized and AI-powered platforms in health research are not designed to replace healthcare …

The Food and Drug Administration (FDA) is nearing approval of a groundbreaking CRISPR-based therapy for sickle cell disease, marking a historic shift from lab experimentation to clinical application. The FDA, …

A recent study published in Current Problems in Diagnostic Radiology compared the performance of OpenAI’s ChatGPT and Google Bard in suggesting appropriate urologic imaging methods based on American College of …

Researchers have developed an automated pain recognition system utilizing artificial intelligence (AI) to assess patients’ pain levels before, during, and after surgery. The system, presented at the ANESTHESIOLOGY® 2023 annual …